We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
The Joint Research Centre (JRC) and the National Centre for Nuclear Research (NCBJ) of Poland signed today a collaboration agreement focusing on nuclear material research, security, and medical applications.
The Collaboration Agreement will be of mutual benefit for both organisations and allows developing synergies in different areas of nuclear research. It will support fostering JRC scientific excellence by pursuing common research and implementing the JRC Education and Training strategy. In addition, the agreement opens JRC's research infrastructure to external scientific use.
On 8 June 2016, Commissioners Tibor Navracsics and Günther Oettinger took part in the ground-breaking ceremony of a new laboratory building at the JRC site in Karlsruhe, Germany.
The European Union and the United States of America, in cooperation with the International Atomic Energy Agency (IAEA), share the international responsibility to develop and promote systems and measures for the prevention of, detection of, and response to nuclear and other radioactive materials out of regulatory control.
Initiated by the European Union and the United States of America, the ITRAP+10 test campaign evaluated the performance of commercially available radiation detection equipment against consensus standards.
Governmental nuclear security experts, front line officers and technical support organisations took part in a nuclear security simulation exercise organised in cooperation with the International Atomic Energy Agency.
Counter Nuclear Smuggling Workshop 2016 - a high-level workshop co-hosted by the European Commission's Joint Research Centre (JRC) and the United States Department of State in the run-up to the 2016 Nuclear Security Summit.
Six road and railway border crossings with Uzbekistan and Afghanistan are now equipped with radiation portal monitors, supported by a mobile laboratory, which will allow customs authorities to detect radioactive materials.
A JRC invention initially stemming from its research in the nuclear sector will soon be used by hospitals for minimally-invasive robotic surgery.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters.